Build Your Comparison

Side-by-side financial analysis
ALNT logo
ALNT
EMR logo
EMR
JPM logo
JPM
ROK logo
ROK
AME logo
AME
Try popular comparisons:

Stock Comparison

ALNT vs EMR vs JPM vs ROK vs AME

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ALNT
Allient Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$1.55B
5Y Perf.+158.8%
EMR
Emerson Electric Co.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$80.13B
5Y Perf.+130.6%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%
ROK
Rockwell Automation, Inc.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$51.61B
5Y Perf.+115.7%
AME
AMETEK, Inc.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$52.03B
5Y Perf.+154.1%

ALNT vs EMR vs JPM vs ROK vs AME — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ALNT logoALNT
EMR logoEMR
JPM logoJPM
ROK logoROK
AME logoAME
IndustryHardware, Equipment & PartsIndustrial - MachineryBanks - DiversifiedIndustrial - MachineryIndustrial - Machinery
Market Cap$1.55B$80.13B$896.00B$51.61B$52.03B
Revenue (TTM)$561M$18.32B$280.33B$8.80B$7.60B
Net Income (TTM)$24M$2.44B$57.05B$1.09B$1.53B
Gross Margin31.2%52.7%60.0%52.5%36.6%
Operating Margin8.4%19.8%25.9%19.1%26.2%
Forward P/E36.2x22.0x14.4x35.5x27.9x
Total Debt$197M$13.76B$942.38B$3.65B$2.28B
Cash & Equiv.$41M$1.54B$343.34B$468M$458M

ALNT vs EMR vs JPM vs ROK vs AMELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ALNT
EMR
JPM
ROK
AME
StockJun 20Jun 26Return
Allient Inc. (ALNT)100258.8+158.8%
Emerson Electric Co. (EMR)100230.6+130.6%
JPMorgan Chase & Co. (JPM)100341.0+241.0%
Rockwell Automation… (ROK)100215.7+115.7%
AMETEK, Inc. (AME)100254.1+154.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: ALNT vs EMR vs JPM vs ROK vs AME

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: JPM leads in 3 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. AMETEK, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. ALNT and ROK also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇JPM emerged as the overall leader. Track its performance:
ALNT
Allient Inc.
The Momentum Pick

ALNT ranks third and is worth considering specifically for momentum.

  • +166.9% vs EMR's +14.6%
Best for: momentum
EMR
Emerson Electric Co.
The Quality Angle

Among these 5 stocks, EMR doesn't own a clear edge in any measured category.

Best for: industrials exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 15 yrs, beta 0.94, yield 1.9%
  • 465.8% 10Y total return vs ALNT's 314.8%
  • PEG 0.81 vs ALNT's 5.32
  • Lower P/E (14.4x vs 27.9x), PEG 0.81 vs 2.50
Best for: income & stability and long-term compounding
ROK
Rockwell Automation, Inc.
The Niche Pick

ROK is the clearest fit if your priority is efficiency.

  • 9.7% ROA vs JPM's 1.3%, ROIC 15.1% vs 4.5%
Best for: efficiency
AME
AMETEK, Inc.
The Growth Play

AME is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.

  • Rev growth 6.6%, EPS growth 7.9%, 3Y rev CAGR 6.4%
  • Lower volatility, beta 0.93, Low D/E 21.5%, current ratio 1.06x
  • Beta 0.93, yield 0.5%, current ratio 1.06x
  • 6.6% revenue growth vs ROK's 1.0%
Best for: growth exposure and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthAME logoAME6.6% revenue growth vs ROK's 1.0%
ValueJPM logoJPMLower P/E (14.4x vs 27.9x), PEG 0.81 vs 2.50
Quality / MarginsJPM logoJPM20.4% margin vs ALNT's 4.3%
Stability / SafetyAME logoAMEBeta 0.93 vs ALNT's 2.10, lower leverage
DividendsJPM logoJPM1.9% yield, 15-year raise streak, vs EMR's 1.5%
Momentum (1Y)ALNT logoALNT+166.9% vs EMR's +14.6%
Efficiency (ROA)ROK logoROK9.7% ROA vs JPM's 1.3%, ROIC 15.1% vs 4.5%

ALNT vs EMR vs JPM vs ROK vs AME — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Infrastructure Stocks Theme

These companies are key players in the Infrastructure Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
ALNTAllient Inc.
FY 2025
Industrial
50.8%$268M
Vehicle
18.4%$97M
Medical
15.5%$82M
Aerospace & Defense
15.4%$81M
EMREmerson Electric Co.
FY 2025
Intelligent Devices
68.5%$12.4B
Software and Control
31.5%$5.7B
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
ROKRockwell Automation, Inc.
FY 2025
Intelligent Devices Segment
45.0%$3.8B
Software And Control Segment
28.6%$2.4B
Lifecycle Services Segment
26.4%$2.2B
AMEAMETEK, Inc.
FY 2025
Electronic Instruments Group
66.5%$4.9B
Electromechanical Group
33.5%$2.5B

ALNT vs EMR vs JPM vs ROK vs AME — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGAME

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 3 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 500.1x ALNT's $561M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to ALNT's 4.3%. On growth, ROK holds the edge at +11.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricALNT logoALNTAllient Inc.EMR logoEMREmerson Electric …JPM logoJPMJPMorgan Chase & …ROK logoROKRockwell Automati…AME logoAMEAMETEK, Inc.
RevenueTrailing 12 months$561M$18.3B$280.3B$8.8B$7.6B
EBITDAEarnings before interest/tax$72M$4.7B$81.4B$1.9B$2.3B
Net IncomeAfter-tax profit$24M$2.4B$57.0B$1.1B$1.5B
Free Cash FlowCash after capex$41M$3.1B$100.9B$1.3B$1.7B
Gross MarginGross profit ÷ Revenue+31.2%+52.7%+60.0%+52.5%+36.6%
Operating MarginEBIT ÷ Revenue+8.4%+19.8%+25.9%+19.1%+26.2%
Net MarginNet income ÷ Revenue+4.3%+13.3%+20.4%+12.4%+20.1%
FCF MarginFCF ÷ Revenue+7.3%+17.0%+36.0%+15.2%+22.4%
Rev. Growth (YoY)Latest quarter vs prior year+4.6%+2.9%+11.8%+11.3%
EPS Growth (YoY)Latest quarter vs prior year+52.4%+28.2%+16.0%+39.6%+14.5%
JPM leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

JPM leads this category, winning 5 of 7 comparable metrics.

At 16.0x trailing earnings, JPM trades at a 77% valuation discount to ALNT's 69.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs ALNT's 10.18x — a lower PEG means you pay less per unit of expected earnings growth.

MetricALNT logoALNTAllient Inc.EMR logoEMREmerson Electric …JPM logoJPMJPMorgan Chase & …ROK logoROKRockwell Automati…AME logoAMEAMETEK, Inc.
Market CapShares × price$1.6B$80.1B$896.0B$51.6B$52.0B
Enterprise ValueMkt cap + debt − cash$1.7B$92.3B$1.50T$54.8B$53.9B
Trailing P/EPrice ÷ TTM EPS69.22x35.41x16.00x59.89x35.49x
Forward P/EPrice ÷ next-FY EPS est.36.19x21.99x14.40x35.52x27.90x
PEG RatioP/E ÷ EPS growth rate10.18x7.84x0.90x3.18x
EV / EBITDAEnterprise value multiple23.27x18.29x18.36x31.34x28.65x
Price / SalesMarket cap ÷ Revenue2.80x4.45x3.20x6.19x7.03x
Price / BookPrice ÷ Book value/share5.07x3.99x2.47x14.00x4.94x
Price / FCFMarket cap ÷ FCF31.26x30.05x8.88x38.00x31.12x
JPM leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

ROK leads this category, winning 5 of 9 comparable metrics.

ROK delivers a 29.6% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $8 for ALNT. AME carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), ROK scores 8/9 vs JPM's 5/9, reflecting strong financial health.

MetricALNT logoALNTAllient Inc.EMR logoEMREmerson Electric …JPM logoJPMJPMorgan Chase & …ROK logoROKRockwell Automati…AME logoAMEAMETEK, Inc.
ROE (TTM)Return on equity+8.0%+12.1%+15.9%+29.6%+14.4%
ROA (TTM)Return on assets+4.1%+5.8%+1.3%+9.7%+9.6%
ROICReturn on invested capital+7.7%+8.2%+4.5%+15.1%+12.1%
ROCEReturn on capital employed+9.4%+10.0%+8.9%+18.5%+15.0%
Piotroski ScoreFundamental quality 0–967587
Debt / EquityFinancial leverage0.65x0.68x2.60x0.98x0.21x
Net DebtTotal debt minus cash$156M$12.2B$599.0B$3.2B$1.8B
Cash & Equiv.Liquid assets$41M$1.5B$343.3B$468M$458M
Total DebtShort + long-term debt$197M$13.8B$942.4B$3.6B$2.3B
Interest CoverageEBIT ÷ Interest expense2.31x6.46x0.74x9.06x23.34x
ROK leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — ALNT and JPM each lead in 3 of 6 comparable metrics.

A $10,000 investment in ALNT five years ago would be worth $25,019 today (with dividends reinvested), compared to $15,772 for EMR. Over the past 12 months, ALNT leads with a +166.9% total return vs EMR's +14.6%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs AME's 15.1% — a key indicator of consistent wealth creation.

MetricALNT logoALNTAllient Inc.EMR logoEMREmerson Electric …JPM logoJPMJPMorgan Chase & …ROK logoROKRockwell Automati…AME logoAMEAMETEK, Inc.
YTD ReturnYear-to-date+64.5%+6.2%-0.5%+15.9%+8.8%
1-Year ReturnPast 12 months+166.9%+14.6%+21.8%+43.0%+26.9%
3-Year ReturnCumulative with dividends+136.9%+77.8%+138.2%+53.3%+52.3%
5-Year ReturnCumulative with dividends+150.2%+57.7%+118.2%+71.8%+70.4%
10-Year ReturnCumulative with dividends+314.8%+216.5%+465.8%+333.4%+397.2%
CAGR (3Y)Annualised 3-year return+33.3%+21.1%+33.6%+15.3%+15.1%
Evenly matched — ALNT and JPM each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ROK and AME each lead in 1 of 2 comparable metrics.

AME is the less volatile stock with a 0.93 beta — it tends to amplify market swings less than ALNT's 2.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ROK currently trades 98.1% from its 52-week high vs EMR's 86.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricALNT logoALNTAllient Inc.EMR logoEMREmerson Electric …JPM logoJPMJPMorgan Chase & …ROK logoROKRockwell Automati…AME logoAMEAMETEK, Inc.
Beta (5Y)Sensitivity to S&P 5002.10x1.61x0.94x1.52x0.93x
52-Week HighHighest price in past year$95.65$165.15$337.25$468.11$243.18
52-Week LowLowest price in past year$33.02$122.64$262.71$305.44$174.43
% of 52W HighCurrent price vs 52-week peak+95.5%+86.6%+95.1%+98.1%+93.4%
RSI (14)Momentum oscillator 0–10070.753.959.156.048.6
Avg Volume (50D)Average daily shares traded217K2.5M7.0M623K1.0M
Evenly matched — ROK and AME each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — EMR and JPM each lead in 1 of 2 comparable metrics.

Analyst consensus: ALNT as "Buy", EMR as "Buy", JPM as "Buy", ROK as "Hold", AME as "Buy". Consensus price targets imply 14.4% upside for EMR (target: $164) vs -15.9% for ALNT (target: $77). For income investors, JPM offers the higher dividend yield at 1.86% vs ALNT's 0.13%.

MetricALNT logoALNTAllient Inc.EMR logoEMREmerson Electric …JPM logoJPMJPMorgan Chase & …ROK logoROKRockwell Automati…AME logoAMEAMETEK, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHoldBuy
Price TargetConsensus 12-month target$76.80$163.62$339.75$468.63$248.50
# AnalystsCovering analysts541613929
Dividend YieldAnnual dividend ÷ price+0.1%+1.5%+1.9%+1.1%+0.5%
Dividend StreakConsecutive years of raises05415166
Dividend / ShareAnnual DPS$0.12$2.10$5.95$5.23$1.23
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.6%+3.9%+0.8%+0.8%
Evenly matched — EMR and JPM each lead in 1 of 2 comparable metrics.
Key Takeaway

JPM leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). ROK leads in 1 (Profitability & Efficiency). 3 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 2 of 6 categories
Loading custom metrics...

ALNT vs EMR vs JPM vs ROK vs AME: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ALNT or EMR or JPM or ROK or AME a better buy right now?

For growth investors, AMETEK, Inc.

(AME) is the stronger pick with 6. 6% revenue growth year-over-year, versus 1. 0% for Rockwell Automation, Inc. (ROK). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Allient Inc. (ALNT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ALNT or EMR or JPM or ROK or AME?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 0x versus Allient Inc. at 69. 2x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Allient Inc. 's 5. 32x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — ALNT or EMR or JPM or ROK or AME?

Over the past 5 years, Allient Inc.

(ALNT) delivered a total return of +150. 2%, compared to +57. 7% for Emerson Electric Co. (EMR). Over 10 years, the gap is even starker: JPM returned +465. 8% versus EMR's +216. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ALNT or EMR or JPM or ROK or AME?

By beta (market sensitivity over 5 years), AMETEK, Inc.

(AME) is the lower-risk stock at 0. 93β versus Allient Inc. 's 2. 10β — meaning ALNT is approximately 126% more volatile than AME relative to the S&P 500. On balance sheet safety, AMETEK, Inc. (AME) carries a lower debt/equity ratio of 21% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ALNT or EMR or JPM or ROK or AME?

By revenue growth (latest reported year), AMETEK, Inc.

(AME) is pulling ahead at 6. 6% versus 1. 0% for Rockwell Automation, Inc. (ROK). On earnings-per-share growth, the picture is similar: Allient Inc. grew EPS 67. 1% year-over-year, compared to -7. 4% for Rockwell Automation, Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ALNT or EMR or JPM or ROK or AME?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus 4. 0% for Allient Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AME leads at 26. 2% versus 8. 7% for ALNT. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ALNT or EMR or JPM or ROK or AME more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Allient Inc. 's 5. 32x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 4x forward P/E versus 36. 2x for Allient Inc. — 21. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EMR: 14. 4% to $163. 62.

08

Which pays a better dividend — ALNT or EMR or JPM or ROK or AME?

All stocks in this comparison pay dividends.

JPMorgan Chase & Co. (JPM) offers the highest yield at 1. 9%, versus 0. 1% for Allient Inc. (ALNT).

09

Is ALNT or EMR or JPM or ROK or AME better for a retirement portfolio?

For long-horizon retirement investors, JPMorgan Chase & Co.

(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Allient Inc. (ALNT) carries a higher beta of 2. 10 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +465. 8%, ALNT: +314. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ALNT and EMR and JPM and ROK and AME?

These companies operate in different sectors (ALNT (Technology) and EMR (Industrials) and JPM (Financial Services) and ROK (Industrials) and AME (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ALNT is a small-cap quality compounder stock; EMR is a mid-cap quality compounder stock; JPM is a large-cap deep-value stock; ROK is a mid-cap quality compounder stock; AME is a mid-cap quality compounder stock. EMR, JPM, ROK, AME pay a dividend while ALNT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.